MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study

被引：0
|
作者：
Fox, R. [1 ]
Oh, J. [2 ]
Arnold, D. [3 ]
Syed, S. [4 ]
Xu, Z. [5 ]
Turner, T. [4 ]
Traboulsee, A. [6 ]
Reich, D. [7 ]
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH USA
[2] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[3] McGill Univ, NeuroRx Res & Montreal Neurol Inst, Montreal, PQ, Canada
[4] Sanofi, Cambridge, MA USA
[5] Sanofi, Bridgewater, MA USA
[6] Univ British Columbia, Vancouver, BC, Canada
[7] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-318
引用
收藏
页码：526 / 527
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [32] Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies
    Kulasekararaj, Austin G.
    Griffin, Morag
    Langemeijer, Saskia
    Usuki, Kensuke
    Kulagin, Alexander
    Ogawa, Masayo
    Yu, Ji
    Mujeebuddin, Arshad
    Nishimura, Jun-ichi
    Lee, Jong Wook
    de Latour, Regis Peffault
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (03) : 205 - 214
  • [33] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, P. J.
    Setty, A.
    Papp, K.
    Van den Bosch, F.
    Tsuji, S.
    Keiserman, M.
    Bu, X.
    Chen, L.
    Mccaskill, R.
    Mcdearmon-Blondell, E.
    Wung, P.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 836 - 837
  • [34] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, Philip J.
    Setty, Arathi
    Papp, Kim
    Van den Bosch, Filip
    Tsuji, Shigeyoshi
    Keiserman, Mauro
    Bu, Xianwei
    Chen, Liang
    Mccaskill, Reva
    Mcdearmon-Blondell, Erin
    Wung, Peter
    Tillett, William
    RHEUMATOLOGY, 2023, 62
  • [35] Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results
    Oh, Jiwon
    Syed, Sana
    Li, Tong
    Salloum, Naji
    Turner, Timothy J.
    Fox, Robert J.
    NEUROLOGY, 2023, 100 (17)
  • [36] Safety and Clinical Efficacy Outcomes from the Long-term Extension Study of Tolebrutinib in Participants with Relapsing Multiple Sclerosis: 3-Year Results
    Oh, Jiwon
    Reich, Daniel
    Traboulsee, Anthony
    Arnold, Douglas L.
    Syed, Sana
    Dukovic, Deborah
    Vargas, Wendy S.
    Turner, Timothy
    Fox, Robert J.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 334 - 335
  • [37] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [38] LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Baraliakos, X.
    Deodhar, A.
    van der Heijde, D.
    van den Bosch, F.
    Magrey, M.
    Maksymowych, W. P.
    Tomita, T.
    Xu, H.
    Massow, U.
    Fleurinck, C.
    Vaux, T.
    Prajapati, C.
    Shepherd-Smith, J.
    Marten, A.
    Gensler, L. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 93 - 94
  • [39] LONG-TERM SAFETY OF FILGOTINIB IN PATIENTS WITH PSA: WEEK 52 SAFETY DATA FROM A PHASE 2 OPENLABEL EXTENSION STUDY
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    RHEUMATOLOGY, 2020, 59
  • [40] Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy
    Beatriz Alvarado-Castillo
    Francisco J. Santa Cruz-Pavlovich
    Celia Gonzalez-Castillo
    Isaac Alejandro Vidal-Paredes
    Leonel Garcia-Benavides
    Maria Elena Rosales-Gradilla
    Jose Navarro-Partida
    BMC Ophthalmology, 23
12345